No 'Dry' Spell for Aridis in Anti-Infectives

By Marie PowersStaff Writer

Wednesday, August 21, 2013

Aridis Pharmaceuticals LLC is a textbook example of the motto that different roads can lead to the same destination.

When co-founders Eric Patzer, president, and Vu Truong, chief scientific officer, launched the company in 2005, they were confident that early wins in anti-infectives using improved formulation and delivery technology would attract venture capital and propel them through clinical studies. Instead, they became masters of grant funding but still managed to assemble a pipeline and ink a solid licensing deal.